Weight loss drug gets US nod to treat sleep apnea

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA). The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the ...
Lilly is also seeking approval for the drug in sleep apnea patients in the U.S. Lilly ... Approval for use beyond weight-loss could be a shot in the arm for the companies at a time when ...